Literature DB >> 10353049

The additional lead electrocardiogram in acute myocardial infarction.

W J Brady1, F Morris.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10353049      PMCID: PMC1343336          DOI: 10.1136/emj.16.3.202

Source DB:  PubMed          Journal:  J Accid Emerg Med        ISSN: 1351-0622


× No keyword cloud information.
  6 in total

1.  THE RECOGNITION OF STRICTLY POSTERIOR MYOCARDIAL INFARCTION BY CONVENTIONAL SCALAR ELECTROCARDIOGRAPHY.

Authors:  J K PERLOFF
Journal:  Circulation       Date:  1964-11       Impact factor: 29.690

2.  Electrocardiographic diagnosis of remote posterior wall myocardial infarction using unipolar posterior lead V9.

Authors:  M W Rich; M Imburgia; T R King; K C Fischer; K L Kovach
Journal:  Chest       Date:  1989-09       Impact factor: 9.410

3.  Significance of ST segment elevations in posterior chest leads (V7 to V9) in patients with acute inferior myocardial infarction: application for thrombolytic therapy.

Authors:  S Matetzky; D Freimark; P Chouraqui; B Rabinowitz; S Rath; E Kaplinsky; H Hod
Journal:  J Am Coll Cardiol       Date:  1998-03-01       Impact factor: 24.094

4.  Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement. HIT-4 Trial Group. Hirudin for Improvement of Thrombolysis.

Authors:  U Zeymer; K L Neuhaus; K Wegscheider; U Tebbe; P Molhoek; R Schröder
Journal:  J Am Coll Cardiol       Date:  1998-10       Impact factor: 24.094

5.  Electrocardiographic evolution of posterior acute myocardial infarction: importance of early precordial ST-segment depression.

Authors:  W E Boden; R E Kleiger; R S Gibson; D J Schwartz; K B Schechtman; R J Capone; R Roberts
Journal:  Am J Cardiol       Date:  1987-04-01       Impact factor: 2.778

6.  Usefulness of three additional electrocardiographic chest leads (V7, V8, and V9) in the diagnosis of acute myocardial infarction.

Authors:  L J Melendez; D T Jones; J R Salcedo
Journal:  Can Med Assoc J       Date:  1978-10-07       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.